Characterization of unique B-cell populations in the circulation of people living with HIV prior to non-Hodgkin lymphoma diagnosis

被引:0
|
作者
Martinez, Laura E. [1 ,2 ]
Comin-Anduix, Begona [3 ,4 ,5 ]
Guemes-Aragon, Miriam [3 ,6 ]
Ibarrondo, Javier [1 ]
Detels, Roger [7 ]
Mimiaga, Matthew J. [7 ]
Epeldegui, Marta [1 ,2 ,3 ]
机构
[1] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Ahmanson Translat Theranost Div, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Hematol & Oncol, Los Angeles, CA 90024 USA
[7] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
美国国家卫生研究院;
关键词
mass cytometry; B-cells; B regulatory cells; HIV plus cART-na & iuml; ve; HIV plus pre-NHL (cART-na & iuml; ve); INDUCED CYTIDINE DEAMINASE; IMMUNE ACTIVATION; DISEASE PROGRESSION; CHEMOKINE RECEPTORS; EXPRESSION; INFECTION; MARKERS; BIOMARKERS; CYTOKINES; RISK;
D O I
10.3389/fimmu.2024.1441994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
People living with HIV (PLWH) are at higher risk of developing lymphoma. In this study, we performed cytometry by time-of-flight (CyTOF) on peripheral blood mononuclear cells of cART-na & iuml;ve HIV+ individuals and cART-na & iuml;ve HIV+ individuals prior to AIDS-associated non-Hodgkin lymphoma (pre-NHL) diagnosis. Participants were enrolled in the Los Angeles site of the MACS/WIHS Combined Cohort Study (MWCCS). Uniform Manifold Approximation and Projection (UMAP) and unsupervised clustering analysis were performed to identify differences in the expression of B-cell activation markers and/or oncogenic markers associated with lymphomagenesis. CD10+CD27- B cells, CD20+CD27- B cells, and B-cell populations with aberrant features (CD20+CD27+CXCR4+CD71+ B cells and CD20+CXCR4+cMYC+ B cells) were significantly elevated in HIV+ cART-na & iuml;ve compared to HIV-negative samples. CD20+CD27+CD24+CXCR4+CXCR5+ B cells, CD20+CD27+CD10+CD24+CXCR4+cMYC+ B cells, and a cluster of CD20+CXCR4hiCD27-CD24+CXCR5+CD40+CD4+AICDA+ B cells were significantly elevated in HIV+ pre-NHL (cART-na & iuml;ve) compared to HIV+ cART-na & iuml;ve samples. A potentially clonal cluster of CD20+CXCR4+CXCR5+cMYC+AICDA+ B cells and a cluster of germinal center B-cell-like cells (CD19-CD20+CXCR4+Bcl-6+PD-L1+cMYC+) were also found in the circulation of HIV+ pre-NHL (cART-na & iuml;ve) samples. Moreover, significantly elevated clusters of CD19+CD24hiCD38hi cMYC+ AICDA+ B regulatory cells were identified in HIV+ pre-NHL (cART-na & iuml;ve) compared to HIV+ cART-na & iuml;ve samples. The present study identifies unique B-cell subsets in PLWH with potential pre-malignant features that may contribute to the development of pre-tumor B cells in PLWH and that may play a role in lymphomagenesis.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B
    Kleinstern, Geffen
    Abu Seir, Rania
    Perlman, Riki
    Abdeen, Ziad
    Khatib, Areej
    Elyan, Husein
    Dann, Eldad J.
    Kedmi, Meirav
    Ellis, Martin
    Nagler, Arnon
    Amir, Gail
    Ben Yehuda, Dina
    Safadi, Rifaat
    Paltiel, Ora
    HAEMATOLOGICA, 2016, 101 (07) : 303 - 306
  • [32] HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems
    Milovanova, S. Yu
    Lysenko , L., V
    Milovanova, L. Yu
    Mrykhin, N. N.
    Russkih, A., V
    Muchin, N. A.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (06) : 112 - 120
  • [33] Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
    Kato, Harumi
    Yamamoto, Kazuhito
    Taji, Hirofumi
    Oki, Yasuhiro
    Chihara, Dai
    Seto, Masao
    Kagami, Yoshitoyo
    Morishima, Yasuo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 483 - 489
  • [34] Disseminated nocardiosis in a patient with AIDS and B-cell non-Hodgkin's lymphoma: a case report
    Reveron, Delvis R.
    Flora-Noda, David M.
    Soto, Lily M.
    Dolande, Maribel
    Frey, Juan
    Chaurio, Aleiram
    Ruiz-Alayon, Barbara D.
    Caldera, Jocays
    Carrion-Nessi, Fhabian S.
    Forero-Pena, David A.
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [35] Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma
    Makita, S.
    Tobinai, K.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1086 - 1089
  • [36] Aberrant expression of the CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma
    Song, Aiqin
    Ye, Junli
    Zhang, Kunpeng
    Yu, Hongsheng
    Gao, Yanhua
    Wang, Hongfang
    Sun, Lirong
    Xing, Xiaoming
    Yang, Kun
    Zhao, Min
    LEUKEMIA RESEARCH, 2015, 39 (05) : 536 - 543
  • [37] Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults
    Gardenswartz, Aliza
    Cairo, Mitchell S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (05):
  • [38] Primary cutaneous large B-cell non-Hodgkin lymphoma in first-degree relatives
    Colovic, M.
    Vidovic, A.
    Colovic, N.
    Perunicic-Jovanovic, M.
    Tomin, D.
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (06) : 425 - 427
  • [39] Investigation of Epstein-Barr Virus as a Potential Cause of B-Cell Non-Hodgkin Lymphoma in a Prospective Cohort
    De Roos, Anneclaire J.
    Martinez-Maza, Otoniel
    Jerome, Keith R.
    Mirick, Dana K.
    Kopecky, Kenneth J.
    Madeleine, Margaret M.
    Magpantay, Larry
    Edlefsen, Kerstin L.
    LaCroix, Andrea Z.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (10) : 1747 - 1755
  • [40] Clinical Features and Prognosis of Patients with COVID-19 and B-Cell Non-Hodgkin Lymphoma
    Lin, Ya-Qing
    Li, Na
    Wu, Yan-Li
    Ma, Jin-Bao
    Gao, Hai-Nv
    Zhang, Xuan
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4501 - 4510